FDAFinal Rule
Medical Devices; Immunology and Microbiology Devices; Classification of the Microbial Nucleic Acid Storage and Stabilization Device
HealthcareTechnology
Ad Space (leaderboard)
Summary
The FDA is officially classifying a new type of medical device that stores and preserves genetic material from microorganisms (bacteria, viruses, etc.) for testing purposes. This classification helps ensure these storage devices are safe and effective for use in medical laboratories and diagnostic testing.
Key Points
- 1The FDA is categorizing a device designed to collect, store, and keep genetic material from germs stable for later analysis in medical labs
- 2This classification establishes safety and quality standards that manufacturers must follow when producing these storage devices
- 3The rule affects medical device makers, diagnostic laboratories, and hospitals that need to store microbial samples for disease testing
- 4Properly classified devices help ensure accurate testing results for patients and reduce risks of sample contamination or degradation
- 5Manufacturers will need to meet FDA requirements and potentially submit their devices for review before selling them in the United States
Impact Assessment
If you are a manufacturer of microbial nucleic acid storage devices, this means you must now comply with FDA classification requirements to legally market and distribute your products for diagnostic testing in medical laboratories.
Impact Level
Moderate
Geographic Scope
National
Compliance Cost
Moderate
Who is Affected
ManufacturersHealthcare ProvidersTechnology CompaniesImporters/Exporters
Key Dates
Published
May 9, 2025
Regulatory Connections
Authorized By
Amends CFR Sections
21 CFR Part 86021 CFR Part 864
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
Ad Space (rectangle)